CD25+ T Cells Induce Helicobacter Pylori-specific CD25- T-cell Anergy but Are Not Required to Maintain Persistent Hyporesponsiveness
Overview
Affiliations
The gastric pathogen Helicobacter pylori infects over half the world's population. The lifelong infection induces gastric inflammation but the host fails to generate protective immunity. To study the lack of protective H. pylori immunity, CD4(+)CD25(+) T(reg) cells were investigated for their ability to down-regulate H. pylori-specific CD4(+)CD25(-) cells in a murine model. CD25(-) lymphocytes from infected mice were hyporesponsive to antigenic stimulation in vitro even in the absence of CD25(+) T(reg) cells unless treated with high-dose IL-2. Transfer of CD45RB(hi) naïve CD25(-) cells from infected mice into rag1(-/-) mice challenged with H. pylori resulted in severe gastritis and reduced bacterial loads, whereas transfer of CD45RB(lo) memory CD25(-) cells from H. pylori-infected mice resulted in only mild gastritis and persistent infection. CD25(-) cells stimulated in the absence of CD25(+) cells in rag1(-/-) mice promoted bacterial clearance, but lost this ability when subsequently transferred to WT mice harboring CD25(+) cells. These results demonstrate that CD25(+) cells induce anergy in CD25(-) cells in response to H. pylori infection but are not required to maintain hyporesponsiveness. In addition, CD25(+) cells are able to suppress previously activated CD25(-) cells when responding to H. pylori challenge in vivo.
Yao B, Xu X, Liu W, Zhang Q, Wang W, Huang Z Immun Inflamm Dis. 2023; 11(1):e768.
PMID: 36705412 PMC: 9846114. DOI: 10.1002/iid3.768.
Male-Dependent Promotion of Colitis in 129 Mice Co-Infected with and .
Ge Z, Ge L, Muthupalani S, Feng Y, Fox J Int J Mol Sci. 2020; 21(23).
PMID: 33255175 PMC: 7727654. DOI: 10.3390/ijms21238886.
Kuczma M, Szurek E, Cebula A, Ngo V, Pietrzak M, Kraj P Mucosal Immunol. 2020; 14(2):443-454.
PMID: 33139845 PMC: 7946630. DOI: 10.1038/s41385-020-00349-4.
A Case of Persistent Helicobacter pylori Infection Occurring with Anti-IgE Immunosuppression.
Zandman D, Hahn W, Moss S ACG Case Rep J. 2015; 1(1):16-8.
PMID: 26157810 PMC: 4435255. DOI: 10.14309/crj.2013.8.
Vaccinating against Helicobacter pylori in the developing world.
Zawahir S, Czinn S, Nedrud J, Blanchard T Gut Microbes. 2013; 4(6):568-76.
PMID: 24253617 PMC: 3928166. DOI: 10.4161/gmic.27093.